Dansk
Nederlands
English
Suomi
Français
Deutsch
Ελληνικά
Italiano
Norsk
Polski
Português
Español
Svenska
Ipamorelin
€ 57,45
Don't forget the reconstitution water
Required for dissolving freeze-dried peptides.
All products are intended for laboratory research only and are not suitable for human or animal consumption. By purchasing, the buyer agrees to use these products in accordance with all applicable laws.
This substance has not been evaluated or approved by the European (EMA), American (FDA) or Dutch (MEB/IGJ) medicines authorities for any human or veterinary use. No medical, therapeutic, diagnostic or preventive use is claimed or implied.
Ipamorelin is a synthetic growth hormone-releasing peptide (GHRP) that is being studied extensively in molecular and endocrine research. It is designed to selectively interact with the ghrelin receptor (GHS-R), a key component of pathways involved in growth hormone signaling and regulatory processes.
Due to its selective mechanism of action, Ipamorelin is often used in research on receptor-mediated signaling, pathway modulation, and interactions within the endocrine system. The targeted activity profile makes it particularly relevant for studies of controlled signal responses within experimental models.
History of Ipamorelin
Ipamorelin was developed within research into selective GHRP compounds that can specifically activate the ghrelin receptor pathway. Early studies focused on understanding how certain peptides could affect growth hormone signaling without broad receptor interactions.
In later phases, the research was expanded to include molecular signaling, dynamics of endocrine pathways, and receptor specificity, making Ipamorelin a valuable compound within experimental peptide research.
Ipamorelin Structure and Molecular Data
Peptide Name: Ipamorelin
Peptide Type: GHRP (Growth Hormone-Releasing Peptide)
Molecular Formula: C38H49N9O5
Molecular Weight: ~711.85 g/mol
Ipamorelin is a pentapeptide whose structure allows selective interaction with GHS-R receptors. This makes it highly relevant for receptor binding studies and signaling pathway research in laboratory settings.
Ipamorelin Research Findings
Ipamorelin has been extensively investigated in endocrine and molecular models, with a focus on receptor-mediated signaling and pathway dynamics.
Research shows activity related to:
• Ghrelin receptor (GHS-R) interaction and signaling
• Modulation of growth hormone pathways
• Selective receptor activation and signal specificity
• Endocrine and molecular pathway dynamics
Major Research Areas of Ipamorelin
Endocrine Research
Focus on growth hormone signaling and regulatory pathways.
Molecular research
Study of receptor binding, signal specificity and modulation of pathways.
Metabolic Research
Analysis of interactions between hormonal signaling and metabolic processes.
Systemic Research
Research on coordinated signal networks within complex biological systems.
Scientific Relevance of Ipamorelin
Ipamorelin is considered a selective GHRP research peptide that is especially suitable for studying ghrelin receptor interactions and growth hormone signaling.
The targeted mechanism of action allows researchers to analyze specific receptor-driven processes without broad interference with other pathways. This makes it valuable in precision-oriented experimental models.
Due to its selectivity and stability, Ipamorelin remains an important compound in peptide research, molecular biology and endocrine studies.
References
Smith RG. et al. (2005). Ghrelin receptor agonists and endocrine signaling.
Bowers CY. et al. (1998). Growth hormone-releasing peptides and receptor interaction.
Veldhuis JD. et al. (2009). Regulation of growth hormone secretion dynamics.
Our Process
Frequently asked questions
Each batch is independently tested by third-party laboratories using HPLC and mass spectrometry. You can view the Certificate of Analysis (COA) of your specific batch on our lab results page.
Orders placed before 15:00 will be shipped the same day from our EU warehouse. Delivery typically takes 1–3 business days, depending on your location within Europe.